GALNTL5 and differentiated thyroid carcinoma: We therefore confirmed the testicular expression of GALNTL5 using sections (Fig. 8B), and then, we employed tumor TMAs for endometrium (EM1021a, UT721) and thyroid papillary carcinoma (HThy‐Pap120CS‐01) for further analysis (Fig. S5B).